Traws Pharma, Inc. — Director's Dealing 2015

Oct 1, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Onconova Therapeutics, Inc. (ONTX)
CIK: 0001130598
Period of Report: 2015-09-25

Reporting Person: Guerin Mark Patrick (Chief Accounting Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-09-25	Stock Option (right to purchase)	$1.48	A	17500	Acquired	2025-09-25	Common Stock (17500)	Direct

Footnotes

F1: These options vest over four years in 48 equal monthly installments.